By: Jennifer Galvet, PharmD Candidate c/o 2024 Introduction The British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca has agreed to sell its rights to two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million. This decision allows AstraZeneca to reinvest in the company’s main areas of focus: cardiovascular, renal and metabolism, cancer, respiratory, inflammation and…

By: Daniela Farzadfar, PharmD,PGY-1 Resident at Long Island Jewish Medical Center              In March 2020, the World Health Organization (WHO) declared coronavirus disease- 2019 (COVID-19) a global pandemic. 1 To date, over 30 million cases of COVID-19 have been reported in the United States and drug companies have been scrambling to develop therapies for the…

By: Zarnab Jillani PharmD Candidate c/o 2022              The link between diabetes and Alzheimer’s disease (AD) is a new and ongoing debate given the etiology of AD is still not fully understood. Diabetes continues to be a major public health crisis as diagnoses around the world continue to rise. Diabetes is a chronic disease that…

By: Bisma Sekhery, PharmD Candidate c/o 2021              Fostemsavir (Rukobia) is a new Food and Drug Administration (FDA) approved antiretroviral agent for the treatment of Human Immunodeficiency Virus (HIV). It was approved in July 2020 for multidrug-resistant HIV-1. It is a pro-drug, metabolized to its active moiety, temsavir, which binds to the gp120 subunit within…

By: Pallak Sharma, PharmD Candidate c/o 2022 and Rebecca Samuel, PharmD Candidate c/o 2022              Statins, some of the most well-known cholesterol lowering medications, have been demonstrating increasing evidence of safety and benefits to the elderly patient population. 5 Statins are a class of medication that can help lower the level of low-density lipoprotein (LDL)…

By: Lyana Sayilar, PharmD Candidate c/o 2022              On August 31, 2020, the FDA approved the first automated diabetes management device for patients aged 2 to 6-years old. The MiniMed 770G System automatically adjusts basal insulin doses based on glucose levels, facilitating the lives of the patient and caregiver. Prior to its approval, patients and/or…

By: Cindy Van, PharmD Candidate c/o 2022, Shireen Farzadeh, PharmD, BCPS              Insomnia is a condition characterized by difficulty falling asleep, staying asleep, or both, despite an adequate opportunity to sleep. Consequently, insomnia can lead to daytime fatigue, difficulty concentrating, and irritability. This condition can be categorized into short-term and chronic insomnia. While short-term insomnia…

By: Tanay Maddula PharmD Candidate c/o 2022               Rybelsus (oral semaglutide) was recently approved by the Food and Drug Administration (FDA) in September 2019 to help control blood sugar in adult patients with Type 2 Diabetes alongside diet and exercise. It is the first oral GLP-1 (glucagon like peptide-1) agonist as typical drugs of this…

By: Jeng Lee, PharmD Candidate c/o 2022               Throughout the past decade, there has been an increase in the prevalence of medical and recreational consumption of cannabis, also referred to as marijuana. 1 These numbers are expected to rise over the upcoming years in the United States as marijuana use is currently legalized in 33…

By: Pooja Dasgupta and Sonya Wadhawan, PharmD Candidates c/o 2025              The coronavirus, also known as SARS CoV-2 or COVID-19, has widely affected various people globally. The study of SARS CoV-2 has shifted from studying individuals and their unique symptoms during their disease duration to studying different populations and their backgrounds that increase the risk…